A Fusion-Inhibiting Peptide against Rift Valley Fever Virus Inhibits Multiple, Diverse Viruses
暂无分享,去创建一个
Anders Wallqvist | Daniel R. Ripoll | Jeffrey W. Koehler | Shannon L. Taylor | Robert F. Garry | A. Wallqvist | D. Ripoll | R. Garry | M. Guttieri | J. Koehler | Jeffrey M. Smith | K. Spik | C. Badger | Rebecca J Grant | M. Ogg | C. Schmaljohn | Connie S. Schmaljohn | Kristin W. Spik | Catherine V. Badger | Rebecca J. Grant | Monica M. Ogg | Mary C. Guttieri
[1] Y. Modis,et al. Crystal structure of glycoprotein C from Rift Valley fever virus , 2013, Proceedings of the National Academy of Sciences.
[2] M. Rossmann,et al. Release of Dengue Virus Genome Induced by a Peptide Inhibitor , 2012, PloS one.
[3] S. Harrison,et al. Small-Molecule Inhibitors of Dengue-Virus Entry , 2012, PLoS pathogens.
[4] A. Wallqvist,et al. Novel plant-derived recombinant human interferons with broad spectrum antiviral activity , 2011, Antiviral research.
[5] M. Baker,et al. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine encephalitis virus , 2011, The EMBO journal.
[6] K. Stiasny,et al. Mutational Analysis of the Zippering Reaction during Flavivirus Membrane Fusion , 2011, Journal of Virology.
[7] Y. Shai,et al. Insights into the mechanism of HIV-1 envelope induced membrane fusion as revealed by its inhibitory peptides , 2011, European Biophysics Journal.
[8] Ram Samudrala,et al. Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides , 2010, PLoS neglected tropical diseases.
[9] Augustine Goba,et al. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. , 2010, The American journal of tropical medicine and hygiene.
[10] S. Harrison,et al. Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate , 2010, PLoS pathogens.
[11] I. Adam,et al. Manifestations of severe Rift Valley fever in Sudan. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[12] S. White,et al. MPEx: A tool for exploring membrane proteins , 2009, Protein science : a publication of the Protein Society.
[13] Jaques Reifman,et al. PSPP: A Protein Structure Prediction Pipeline for Computing Clusters , 2009, PloS one.
[14] D. Burton,et al. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor , 2008, Nature.
[15] S. Harrison. Viral membrane fusion , 2008, Nature Structural &Molecular Biology.
[16] C. Jonsson,et al. New and Old World hantaviruses differentially utilize host cytoskeletal components during their life cycles. , 2008, Virology.
[17] S. Roche,et al. Structure of the Prefusion Form of the Vesicular Stomatitis Virus Glycoprotein G , 2007, Science.
[18] M. Liao,et al. Functions of the Stem Region of the Semliki Forest Virus Fusion Protein during Virus Fusion and Assembly , 2006, Journal of Virology.
[19] Claire Marie Filone,et al. Development and characterization of a Rift Valley fever virus cell–cell fusion assay using alphavirus replicon vectors , 2006, Virology.
[20] S. Roche,et al. Crystal Structure of the Low-pH Form of the Vesicular Stomatitis Virus Glycoprotein G , 2006, Science.
[21] A. McElroy,et al. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. , 2006, Vaccine.
[22] William C Wimley,et al. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein , 2006, Virus Research.
[23] Nicole D Tischler,et al. Hantavirus Gc glycoprotein: evidence for a class II fusion protein. , 2005, The Journal of general virology.
[24] M. Liao,et al. Domain III from class II fusion proteins functions as a dominant-negative inhibitor of virus membrane fusion , 2005, The Journal of cell biology.
[25] Scott F Michael,et al. Peptide inhibitors of dengue virus and West Nile virus infectivity , 2005, Virology Journal.
[26] C. Goldsmith,et al. Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. , 2005, Virology.
[27] R. Garry,et al. Theoretical Biology and Medical Modelling Open Access Proteomics Computational Analyses Suggest That the Carboxyl Terminal Glycoproteins of Bunyaviruses Are Class Ii Viral Fusion Protein (beta-penetrenes) Viral Fusion Proteinsbunyavirus Envelope Glycoproteinsproteomics Computational Analysesglycopro , 2022 .
[28] K. Stiasny,et al. Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.
[29] J. Lepault,et al. Conformational change and protein–protein interactions of the fusion protein of Semliki Forest virus , 2004, Nature.
[30] Y. Modis,et al. Structure of the dengue virus envelope protein after membrane fusion , 2004, Nature.
[31] Ali S Khan,et al. Rift Valley fever epidemic in Saudi Arabia: epidemiological, clinical, and laboratory characteristics. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] K. Salzwedel,et al. Direct Evidence that C-Peptide Inhibitors of Human Immunodeficiency Virus Type 1 Entry Bind to the gp41 N-Helical Domain in Receptor-Activated Viral Envelope , 2003, Journal of Virology.
[33] C. Peyrefitte,et al. Rift Valley Fever Virus Infection among French Troops in Chad , 2003, Emerging infectious diseases.
[34] Lei Xie,et al. Using multiple structure alignments, fast model building, and energetic analysis in fold recognition and homology modeling , 2003, Proteins.
[35] Stuart T. Nichol,et al. Genetic Analysis of Viruses Associated with Emergence of Rift Valley Fever in Saudi Arabia and Yemen, 2000-01 , 2002, Emerging infectious diseases.
[36] Christian Drosten,et al. Rapid Detection and Quantification of RNA of Ebola and Marburg Viruses, Lassa Virus, Crimean-Congo Hemorrhagic Fever Virus, Rift Valley Fever Virus, Dengue Virus, and Yellow Fever Virus by Real-Time Reverse Transcription-PCR , 2002, Journal of Clinical Microbiology.
[37] C. Mandl,et al. Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E , 2001, Journal of Virology.
[38] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[39] P. S. Kim,et al. Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] Eric Hunter,et al. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry , 1998, Nature Medicine.
[41] W. Weissenhorn,et al. Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. , 1998, Molecular cell.
[42] M. Bouloy,et al. Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. , 1997, Virus research.
[43] S. Harrison,et al. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.
[44] C. Mandl,et al. Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH , 1995, Journal of virology.
[45] T. Matthews,et al. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. , 1993, AIDS research and human retroviruses.
[46] C. Peters,et al. General aspects of the 1987 Rift Valley fever epidemic in Mauritania. , 1989, Research in virology.
[47] J. Dalrymple,et al. Genetic variation among geographic isolates of Rift Valley fever virus. , 1988, The American journal of tropical medicine and hygiene.
[48] C. Peters,et al. Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. , 1985, The Journal of general virology.
[49] H. Hoogstraal,et al. An epizootic of Rift Valley fever in Egypt in 1977 , 1979, Veterinary Record.
[50] J. R. Hudson,et al. Enzootic hepatitis or rift valley fever. An undescribed virus disease of sheep cattle and man from east africa , 1931 .